Who to call at Labcorp Holdings Inc., and when
Fundz watches for the moments Labcorp Holdings Inc. starts buying, and tells you who to reach.
- An alert the day Labcorp Holdings Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Labcorp Holdings Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Labcorp Holdings Inc.. With Fundz connected, it knows.
Labcorp Holdings Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
www.labcorp.comAI Executive Summary
AI-powered analysis of 8-K filing content
Labcorp's Board of Directors appointed Victor Bulto, President of Novartis U.S. and a member of the Novartis Executive Committee, as a director effective December 1, 2025. The appointment adds a senior pharmaceutical industry executive to the board and was announced in a November 24, 2025 press release.
Key Takeaways
Victor Bulto was appointed to Labcorp's Board of Directors on November 20, 2025, effective December 1, 2025.
Bulto has served as President of Novartis U.S. and as a member of the Novartis Executive Committee since April 2022, and has more than two decades of experience at Novartis across therapeutic areas an
2 more takeaways
Related Filings (19)
19 more filings from Labcorp Holdings Inc. in the last 90 days
Filing Overview
What This Means
Labcorp Holdings Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.